Literature DB >> 23565810

Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower.

M Rodríguez-Créixems1, P Muñoz, P Martín-Rabadán, E Cercenado, M Guembe, E Bouza.   

Abstract

The incidence of central-line-associated bloodstream infection (CLA-BSI) is reported per 1000 days of catheter exposure, mainly in the intensive care unit (ICU), because recording exposure throughout an institution is not always feasible. Confirmation of catheter-related bloodstream infection (CR-BSI) requires specific laboratory testing that identifies the catheter as the source of infection. This information is available in microbiology laboratories and can be assessed using a denominator of 1000 admissions. We evaluated recent trends in the incidence and aetiology of CR-BSI and compared adult ICUs with the remaining areas of the hospital in a retrospective cohort analysis of all confirmed CR-BSIs. During the 8-year study period, we recorded 1208 episodes (8.2% of BSIs) of CR-BSI. After adjusting for the blood cultures drawn, a significant reduction in incidence was observed in adult ICUs (47%), where care bundles had been applied. The reduction was similar irrespective of whether CLA-BSI or CR-BSI was assessed. We recorded a significant reduction in the incidence of Staphylococcus aureus CR-BSI, and a significant increase in the incidence of CR-BSI caused by Enterococcus sp., Gram-negative microorganisms and fungi. The microbiology department may complement CLA-BSI/1000 catheter-days by providing CR-BSI when days of exposure are not available, because both figures are parallel. We demonstrated a significant reduction in the incidence of CR-BSI in recent years in the population admitted to adult ICUs but not in the remaining areas of the hospital. A shift in the aetiological spectrum of CR-BSI may be occurring.
© 2012 The Authors Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Bacteraemia; blood cultures; catheter-related bloodstream infection; catheter-related infections; central line-associated bloodstream infection; vascular catheter

Mesh:

Year:  2013        PMID: 23565810     DOI: 10.1111/1469-0691.12050

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.

Authors:  M Guembe; J Guinea; L J Marcos-Zambrano; A Fernández-Cruz; T Peláez; P Muñoz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  Short-Term Peripheral Venous Catheter-Related Bloodstream Infections: Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a 25-Year Prospective Observational Study.

Authors:  Marco Ripa; Laura Morata; Olga Rodríguez-Núñez; Celia Cardozo; Pedro Puerta-Alcalde; Marta Hernández-Meneses; Juan Ambrosioni; Laura Linares; Marta Bodro; Andrea Valcárcel; Climent Casals; Maria de Los Angeles Guerrero-León; Manel Almela; Carolina Garcia-Vidal; Ana Del Río; Francesc Marco; Josep Mensa; José Antonio Martínez; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

3.  A Real-Time PCR Assay Based on 5.8S rRNA Gene (5.8S rDNA) for Rapid Detection of Candida from Whole Blood Samples.

Authors:  Yi Guo; Jing-Xian Yang; Guo-Wei Liang
Journal:  Mycopathologia       Date:  2015-12-19       Impact factor: 2.574

4.  Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis.

Authors:  Yosuke Nakaya; Mika Imasaki; Michinori Shirano; Katsujun Shimizu; Naoko Yagi; Minako Tsutsumi; Masahiro Yoshida; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Takahisa Yamane
Journal:  Ann Hematol       Date:  2022-07-02       Impact factor: 4.030

5.  Treatment duration for central line-associated infection caused by Enterococcus spp.: a retrospective evaluation of a multicenter cohort.

Authors:  Elena Rosselli Del Turco; Zeno Pasquini; Kristian Scolz; Alberto Amedeo; Giacomo Beci; Maddalena Giglia; Linda Bussini; Sulamita Carvalho-Brugger; Laura Gutiérrez; Sara Tedeschi; Mercè Garcia; Simone Ambretti; Juan M Pericàs; Maddalena Giannella; Pierluigi Viale; Michele Bartoletti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-08-01       Impact factor: 5.103

6.  Magnitude of enterococcal bacteremia in trauma patients admitted for intensive trauma care: a tertiary care experience from South asian country.

Authors:  Nonika Rajkumari; Purva Mathur; Bariamtak Thanbuana; Swaminathan Sajan; Mahesh C Misra
Journal:  J Lab Physicians       Date:  2015 Jan-Jun

7.  Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial.

Authors:  María Jesús Pérez-Granda; José María Barrio; Patricia Muñoz; Javier Hortal; Cristina Rincón; Pablo Martin Rabadán; Maria Sagrario Pernia; Emilio Bouza
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

8.  Surveillance of catheter-related infections: the supplementary role of the microbiology laboratory.

Authors:  Wilhelmina Strasheim; Martha M Kock; Veronica Ueckermann; Ebrahim Hoosien; Andries W Dreyer; Marthie M Ehlers
Journal:  BMC Infect Dis       Date:  2015-01-08       Impact factor: 3.090

9.  Catheter-related infections: does the spectrum of microbial causes change over time? A nationwide surveillance study.

Authors:  Niccolò Buetti; Elia Lo Priore; Andrew Atkinson; Andreas F Widmer; Andreas Kronenberg; Jonas Marschall
Journal:  BMJ Open       Date:  2018-12-22       Impact factor: 2.692

10.  The Profile of Microorganisms Responsible for Port-Related Bacteremia in Pediatric Hemato-Oncological Patients.

Authors:  Ewelina Gowin; Bogna Świątek-Kościelna; Przemysław Mańkowski; Danuta Januszkiewicz-Lewandowska
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.